Umbilical cord blood transplantation (CBT), combined with ultra-low-dose methotrexate (uldMTX) as a graft-versus-host disease (GVHD) prophylaxis, provides superior survival for patients with high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), according …